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Co-Infection with Opportunistic Pathogens Promotes Human Immunodeficiency
Virus Type 1 Infection in Macrophages
Sharon M. Wahl, Teresa Greenwell-Wild, Gang Peng,
Hollie Hale-Donze, and Jan M. Orenstein
Oral Infection and Immunity Branch, National Institute of Dental
Research, National Institutes of Health, Bethesda, Maryland;
Department of Pathology, George Washington University,
Washington, DC
Human immunodeficiency virus type 1 (HIV-1) infection is dependent on susceptible host
cells that express both CD4 and chemokine co-receptors. The co-receptor CCR5 is associated
with primary infection by macrophage-tropic virus isolates, whereas CXCR4 is commonly
associated with T cell– and dual-tropic viruses. Once infected, lymphocytes and macrophages
may replicate HIV-1 or harbor latent virus, depending on environmental factors and cellular
activation. Immune activation is often associated with viremia, which is consistent with en-
hanced infection and viral replication in activated cells harboring virus. In this regard, op-
portunistic infections activate the immune system with the detrimental sequelae of enhanced
viral replication and viremia. Under these conditions, viral expansion extends beyond T cells
to tissue macrophages, many of which are co-infected with opportunistic pathogens. The
opportunistic infections promote macrophage susceptibility to HIV-1 through cytokine mod-
ulation and altered chemokine co-receptors, potential targets for intervention.
Human immunodeficiency virus type 1 (HIV-1) infection re-
quires access to host cells that are susceptible to and capable
of replicating the virus. Cellular susceptibility is dependent
upon membrane expression of CD4 and the chemokine co-
receptors CCR5 and CXCR4 and possibly others, including
CCR3 and CCR2b (reviewed in [1]). Among the susceptible
cellular hosts are CD41 T lymphocytes, dendritic cells, and
mononuclear phagocytes. In blood and in lymphoid tissues,
HIV-1 is primarily associated with CD41 T cells. In the tissues,
dendritic cells trap HIV-1 for presentation to lymphocytes and
arguably replicate virus [2, 3]. Circulating monocytes, on the
other hand, are seldom HIV-1 positive, and in the tissues mac-
rophages are infrequently recognized as viral hosts [4, 5]. How-
ever, this cellular distribution markedly changes in the face of
immune activation, particularly during opportunistic infections
(OIs) [4–7].
The ability of HIV-1 to infect and disable T cells renders the
host susceptible to a variety of OIs. The relentless decline in T
cells due to death or redistribution [8] and the apparent insuf-
ficiency of T cell–derived macrophage-activating agents, such
as interferon (IFN)-g, leave macrophages impotent in micro-
bicidal functions [4].
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For example, unchecked intracellular replication of Myco-
bacterium avium complex (MAC) converts an otherwise non-
pathogen into an opportunist capable of wreaking havoc on
the host immune system [9]. After entering through the gastro-
intestinal mucosa, MAC, phagocytized by macrophages in the
lamina propria, spreads throughout the submucosal tissues and
is transported to lymph nodes. From the lymph nodes, the
organisms enter the circulation, and as a result, disseminated
disease occurs in immunocompromised hosts. The contribution
of MAC to enhanced morbidity and mortality in AIDS is evi-
denced by the ability of antimycobacterial therapy to not only
alleviate MAC pathology but also to inhibit viral replication
[9, 10]. Recent evidence suggests that therapeutic intervention
for other OIs, including Mycobacterium tuberculosis and Pneu-
mocystis carinii, also dampens AIDS-based pathogenesis [7].
The intriguing evidence that OI therapy reduces viremia or
progression of AIDS (or both) prompted further analysis of
tissue deposits of MAC and HIV-1 for assessment of potential
co-regulatory events. Initial analysis of lymphoid tissues co-
infected with HIV-1 and OI revealed dramatic levels of HIV-1
expression. In some cases, the numbers of HIV-1–positive cells
in tissues co-infected with OIs exceeded by 1100-fold that seen
in tissues infected with HIV-1 only (figure 1) [5, 6].
Characterization of Cellular Hosts of HIV
On the basis of morphologic findings, many of the HIV-
1–positive cells in lymphoid tissues that were infected by both
MAC and HIV were phagocytic cells and multinucleated giant
cells. Within the sites of infection, a plethora of macrophages
engorged with acid-fast bacilli was readily apparent. Phago-







ent_3/S457/2191148 by Louisiana State U
niversity user on 11 O
ctober 2021
S458 Wahl et al. JID 1999;179 (Suppl 3)
Figure 1. Enhanced HIV-1 RNA–positive cells in lymph nodes (LN)
co-infected with Mycobacterium avium complex (MAC). LN sections
from patients infected with HIV-1 only or co-infected with HIV-1 and
MAC were subjected to in situ hybridization with 35S-labeled sense (not
shown) and antisense probes for HIV-1 viral RNA before and after
protease treatment, which unmasks complexed HIV-1 [5, 6] (Molecular
Histology, Gaithersburg, MD). Protease pretreatment was necessary to
reveal HIV-1 RNA in hyperplastic LN, whereas in MAC co-infected
tissue, intensity of HIV-1 signal was pronounced even without protease
and further increased after treatment. HIV-1–positive cell numbers were
quantified by image analysis.
Figure 2. Monocytes express CCR5 and CXCR4. Peripheral blood
monocytes were isolated by elutriation and stained with phycoerythrin-
conjugated anti-CD14 (a monocyte antigen) and polyclonal anti-CCR5
generated against synthetic peptide derived from N-terminal region of
CCR5 at 10 mg/mL followed by goat anti-rabbit IgG conjugated with
fluorescein isothiocyanate (FITC) or anti-CXCR4 (PharMingen, San
Diego) and FITC-conjugated goat anti-mouse IgG (Jackson Immuno-
Research Laboratories, West Grove, PA) [6]. Cells were analyzed by
flow cytometry (FACScan; Becton Dickinson, San Jose, CA). Nonad-
herent, nonactivated CD141 monocytes express both CCR5 and
CXCR4.
macrophages, the organisms apparently multiply unimpeded.
Further analysis revealed that many of the cells with HIV-1
RNA, as detected by in situ hybridization, also contained in-
tracellular MAC, which was identified by acid-fast staining and
confirmed the myeloid lineage of the viral host cells [5, 6].
Dual-labeling with immunohistochemical markers revealed
that HIV-1–positive cells often co-expressed CD68, a macro-
phage antigen, as well as the macrophage-specific HAM56
marker [5]. Moreover, the macrophage-associated markers, ly-
sozyme, a1 antitrypsin, and a1 antichymotrypsin, were all dis-
played in these infected cells [6]. In addition, the cellular phe-
notype of the HIV-1–positive cells often included expression of
S100 and p55, two markers generally considered representative
of HIV-1–positive dendritic cells [11]. Because dendritic cells
and myeloid cells share a common CD341 ancestry, the usual
differential expression of these antigens may reflect their unique
patterns of maturation or the influence of microenvironmental
factors (or both). However, within the context of a lymphoid
tissue bombarded with cytokines, microbial products, virus in-
fection, and other factors, the usually distinct phenotypes may
merge. As a consequence, the cellular phenotype expressed un-
der the extreme conditions present in a lymph node infected
with both HIV-1 and an OI may represent a phenotypic spec-
trum of cells with both dendritic cells and myeloid markers.
Regardless of these phenotypic parameters, the convergence of
stimuli within this milieu enables the myeloid cells to become
hosts and incubators for HIV-1.
Mechanisms of Accelerated Viral Replication
Viral expansion in the co-infected tissues is not only aug-
mented but also represents a shift in host cell repertoire. The
transition from infected T cells to a predominance of HIV-1–
positive macrophages may represent a change in susceptibility
to infection or a change in the pace of viral replication. The
shift in host cell is, in part, due to the depletion of T cells that
typifies advanced HIV-1 disease [8]. In the absence of a de-
tectable OI, the progression from follicular hyperplasia to fol-
licular involution and lymphocyte depletion and the elevated
viral replication or viremia may not be as evident. With the
emergence of an OI, however, lymph node architecture and T
cell numbers deteriorate and macrophages proportionally in-
crease. To explore the potential mechanisms whereby these my-
eloid cells become a pivotal target of the virus, we evaluated
the ability of the commonly encountered OI (MAC) to influence
parameters contributing to virus internalization.
The chemokine receptors CCR5 and CXCR4, and possibly
CCR3 and CCR2b, function in concert with CD4 to permit
viral fusion and entry into cells [1]. Of these seven transmem-
brane domain, G protein-coupled co-receptors, CCR5 is used
preferentially by many primary or macrophage-tropic HIV-1
isolates, CXCR4 functions in the entry of T cell or dual-tropic
virus, and CCR3 and CCR2b appear more restricted and less
critical [1]. Monocytes freshly isolated from peripheral blood
and identified by the CD14 marker express both CCR5 and







ent_3/S457/2191148 by Louisiana State U
niversity user on 11 O
ctober 2021
JID 1999;179 (Suppl 3) Opportunistic Infections and HIV S459
macrophage infection, their levels of expression were monitored
after exposure to MAC antigens. Peripheral blood monocytes
were cultured in suspension or for a week as adherent mono-
layers and then stimulated with MAC antigens. Not only did
MAC antigens enhance CCR5 expression at the mRNA level,
but cell surface CCR5 was increased as determined by flow
cytometry using a polyclonal anti-CCR5 antibody [6]. CD4
levels measured in parallel were not enhanced by MAC anti-
gens, nor were CXCR4 receptors. Similarly, infection of ad-
herent monocyte/macrophages with viable M. avium augmented
CCR5 on these cells, increasing both the number of CCR51
cells and the intensity of staining on individual cells. These data
suggest that OI, by modulating one of the requisite HIV-1 entry
points on macrophages, can enhance susceptibility to virus in-
fection. Moreover, these in vitro observations reflect the sub-
stantial increase in CCR5-expressing cells detected within lym-
phoid tissues that are co-infected with HIV-1 and MAC
compared with those infected with HIV-1 only [6].
In addition to influencing the initial stages of infection, OI
appear to up-regulate cytokines, which may, in turn, contribute
to the regulation of viral replication in an autocrine or paracrine
fashion. In this regard, MAC stimulates tumor necrosis factor
(TNF)-a expression, which under appropriate conditions, can
enhance viral replication [12–13]. During disseminated MAC
infection, elevated TNF-a levels are also reported in the cir-
culation of patients [14]. Besides influencing viral replication,
TNF-a may also contribute to enhanced cofactor expression.
Characterization of the promoter region of CCR5 revealed con-
sensus sequences for NF-kB binding sites [15], which suggests
that MAC may either directly influence receptor expression or,
by up-regulating TNF-a, indirectly augment CCR5 transcrip-
tion through NF-kB. The presence of three IFN-stimulated re-
sponse elements in the CCR5 promoter [15] also implicates a
role for IFN-g in the regulation of this pathway (Peng et al.,
unpublished observations). Thus, multiple factors in the com-
plex milieu of co-infection may be critical in the dramatically
elevated levels of viral expression, and identification of these
factors may suggest pathways to stop or block entry and
replication.
Inflammation and Virus Production
The presence of cytokines and other cellular, soluble, and
matrix-associated factors that may impact on viral replication
are not limited either to the lymphoid tissue or to sites of OIs.
In fact, tissues characterized by ulceration or other inflam-
matory pathologies without an infectious component are com-
monly sites with augmented viral replication [16] (Wahl et al.,
unpublished observations). The enhanced numbers of cells pos-
sessing HIV-1 in these lesional sites may also reflect inflam-
mation-induced synthesis and secretion of chemokines and
other recruitment factors in addition to regulatory cytokines.
Enhanced expression of chemokine receptors is not only of
significance for virus entry but also for recruitment of potential
new target cells. For example, CCR5 recognizes the CC che-
mokines (MIP1a, MIP1b, and RANTES), which are increased
in response to MAC infection (Hale-Donze et al., unpublished
data) and at sites of inflammation, and they play a role in the
inflammatory process and in the recognition of chemotactic
signals. The presence of these CC chemokines may also bias
host cell selection since T cells are more sensitive to chemokine
inhibition of HIV-1 infection than are macrophages [17].
Collectively, the plethora of inflammatory mediators local-
ized to sites of infection and inflammation appear to have a
profound impact not only on shifting HIV-1 into cells of my-
eloid lineage but also on the extent of local viral replication.
Localized viral production may also be reflected by increased
viremia or declining levels of circulating CD4. Dramatic re-
versals of high virus loads and dwindling CD4 levels have been
associated with inflammation control [16].
Summary
The evidence for a reciprocal relationship between OIs and
HIV-1, in which each favors the other, offers insight into the
overlapping benefits of anti-OI and antiviral therapy. In this
regard, not only does antimycobacterial therapy reduce pro-
gression of HIV-1 disease, but highly active antiretroviral ther-
apy can promote immune responsiveness to mycobacteria [18].
New evidence indicates that the augmentation of HIV-1 is not
restricted to infectious microorganisms but extends to sites of
inflammatory disease. The shared constellation of interacting
events in infection and inflammation may reveal common in-
hibitory targets, and further characterization of the contrib-
uting factors involved in the initiation and maintenance of viral
reservoirs represents a key step in the goal of controlling re-
surgent viral replication and its consequences.
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